Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/20/20 → 4/3/23 |
Funding
- Syneos Health LLC: $16,818.00
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial of the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson's Disease
- Guduru, Zain (PI)